Sugi Predict

Sugi Predict / Compounds / SCHEMBL367892

SCHEMBL367892

SCHEMBL367892

Cn1cc(-n2ccc(=O)c(Cl)n2)cn1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 1/20 0.36
▸ KDM5A P29375 1/20 0.35
▸ KMT2A Q03164 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ POLB P06746 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ AHR P35869 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ RIPK2 O43353 1/20 0.31
▸ CTDSP1 Q9GZU7 1/20 0.30
▸ CCNC P24863 1/20 0.30
▸ CDK8 P49336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13275030 0.83 KMT2A (0.38) CYP2C9KDM5AKMT2AALDH1A1MEN1
SCHEMBL158835 0.82 CYP2C9 (0.35) CYP2C9KDM5AKMT2AALDH1A1CYP1A2
SCHEMBL368618 0.81 CYP2C9 (0.36) CYP2C9KDM5AKMT2AALDH1A1CYP1A2
SCHEMBL13275029 0.81 CYP2C9 (0.36) CYP2C9KDM5AKMT2AALDH1A1MEN1
SCHEMBL10283413 0.81 POLB (0.35) CYP2C9KMT2AALDH1A1CYP1A2CYP3A4
SCHEMBL163545 0.79 CYP2C9 (0.63) CYP2C9KDM5AKMT2AALDH1A1CYP1A2
SCHEMBL173996 0.78 CYP2C9 (0.37) CYP2C9KDM5AKMT2AALDH1A1CYP1A2
SCHEMBL368935 0.76 KDM5A (0.34) CYP2C9KDM5AKMT2AALDH1A1CYP1A2
SCHEMBL22041357 0.75 KDM5A (0.38) KDM5ARIPK2
SCHEMBL22041234 0.75 HTT (0.44) KDM5AALDH1A1HTTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593107-A1 TYROSINE KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-05-22 — — EP disclosed
US-20130116231-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2013-05-09 — — US disclosed
US-20130116231-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2013-05-09 — — US disclosed
US-20130116231-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2013-05-09 — — US disclosed
EP-2515657-A1 TYROSINE KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2012-10-31 — — EP disclosed
US-20120264735-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2012-10-18 — — US disclosed
US-20120264735-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2012-10-18 — — US disclosed
US-20120264735-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. 2012-10-18 — — US disclosed
WO-2012009194-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 — — WO disclosed
WO-2012009194-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 — — WO disclosed
WO-2011084402-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-07-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264735-A1 TYROSINE KINASE INHIBITORS ABL1, MET, ERBB2 CYP2C9 4808/4885KDM5A 1009/4885KMT2A 720/4885
US-20130116231-A1 TYROSINE KINASE INHIBITORS ABL1, ERBB2, MET CYP2C9 4478/4885KDM5A 584/4885KMT2A 730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.